Radiopharmaceutical Market to Register a 6.5% CAGR from 2017 to 2024
The Radiopharmaceutical Market is highly consolidated, wherein the top two players – Siemens Healthineers and GE Healthcare - jointly accounted for more than two-third of the global shares in 2017. Transparency Market Research has observed that the degree of competition is rather high in the market owing to the presence of key players with the availability of advanced technologies and potential productive sources and a high product manufacturing capacity.
View full press release